Farma de Colombia

What Farma de Colombia does

Farma de Colombia is a Colombian pharmaceutical laboratory headquartered in Bogotá, founded in 1960 and operating for 65+ years in the domestic market. The company formulates, manufactures, and commercializes both branded and generic medications across ten therapeutic categories — antibiotics, cardiovascular, dermatological, gastrointestinal, genitourinary, hematopoietic, hormonal, respiratory, musculoskeletal, and vitamins/minerals/supplements. Its portfolio comprises 20+ named brands including BRASARTAN (antihypertensive), CURAM (amoxicillin/clavulanate), KEFLEX (cephalexin), FERINJECTZ (iron supplement), CICADERM (dermatological), MILPAX, STAMYL, CALCIBON-D, KIDCAL, and VONAU FLASH, all developed with INVIMA regulatory approval.

The business operates a sales-led, multi-channel model: products are sold wholesale to Colombian pharmacy chains and independent pharmacies for retail distribution, while a parallel direct sales channel engages physicians and healthcare professionals through detailing and medical marketing. Customer-facing engagement is reinforced through a health-education content platform — a multidisciplinary-reviewed blog and active accounts on Instagram, Facebook, LinkedIn, and YouTube — targeting both HCPs and end consumers (patients). Pricing is not publicly disclosed and is determined at product level under INVIMA-approved prescription or OTC status.

Farma de Colombia is a private subsidiary of Grupo Farma, a diversified pharmaceutical conglomerate with sister operations in Venezuela (Laboratorios Farma), Ecuador (Grupo Farma del Ecuador), and Peru (Farma Konsuma). The group shares corporate governance, an ethics code, and risk-management frameworks. With ~190 employees and no external institutional investment disclosed, the company operates as a single-country, mass-market generic/branded manufacturer without public listings or material M&A activity in the source data.

Name

Farma de Colombia

Legal name

Farma de Colombia

Website

https://farmadecolombia.com

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

101–250 employees

Short description

Farma de Colombia is a Bogotá-based pharmaceutical laboratory, founded in 1960 and part of Grupo Farma. It manufactures and distributes 20+ branded generic and OTC medications across ten therapeutic categories to Colombian pharmacies, healthcare professionals, and patients.

Ownership category

akta.pro rank

Headquarters

HQ city

Bogotá

HQ country

Colombia

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Farma de Colombia generates revenue through the sale of pharmaceutical products including prescription medications and OTC (over-the-counter) products. The company commercializes products across 10 therapeutic categories: antibiotics, cardiovascular, dermatological, gastrointestinal, genitourinary, hematopoietic, hormonal, respiratory, skeletal muscle, and vitamins/minerals/supplements. Products are sold through pharmacies and distributed to healthcare providers and patients throughout Colombia.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Farma de Colombia is a Colombian pharmaceutical laboratory that manufactures and commercializes prescription and over-the-counter (OTC) medications across 10 therapeutic categories, including antibiotics, cardiovascular, dermatological, gastrointestinal, genitourinary, hematopoietic, hormonal, respiratory, and musculoskeletal treatments as well as vitamins, minerals and supplements. The company sells its products through a pharmacy distribution network and via direct engagement with physicians and healthcare professionals throughout Colombia, with all products registered and approved by INVIMA.

Product overview

Farma de Colombia is a pharmaceutical laboratory with more than 65 years of experience in the Colombian market. The company offers a comprehensive portfolio of effective, safe, and scientifically-backed pharmaceutical products organized across 10 specialized therapeutic lines: Antibiotics, Cardiovascular, Dermatological, Gastrointestinal, Genitourinary, Hematopoietic, Hormonal, Respiratory, Skeletal Muscle, and Vitamins/Minerals/Supplements. The product portfolio includes over 20 branded medications such as BRASARTAN (antihypertensive), CALCIBON-D (calcium/vitamin D), CURAM and KEFLEX (antibiotics), FERINJECTZ (iron supplement), and CICADERM (dermatological), among others. Products are developed with high quality standards to improve quality of life for consumers while offering effective alternatives to Colombian healthcare professionals.

Differentiator

Problem solved

Functional benefit

Brands

• BRASARTAN: Cardiovascular product
• CALCIBON-D
• CELECTAN
• CICADERM
• COLYPAN
• CURAM
• EVALAX
• FERINJECT
• GYNOPLUS
• HERREX
• KEFLEX
• MILPAX
• STAMYL

Products and services

• BRASARTAN

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core and minor.

• Grupo FarmacoreStrategic or Co-development PartnerFarma de Colombia is part of Grupo Farma, a pharmaceutical group with operations across Latin America. Grupo Farma includes subsidiaries in Venezuela (Laboratorios Farma), Ecuador (Grupo Farma del Ecuador), and Peru (Farma Konsuma). The group shares corporate governance, ethics codes, and risk management policies.
• VidaminaminorOthersVidamina is listed as an ally of Farma de Colombia. Vidamina.global appears to be a related health platform providing iron and health supplement information. Products like Maltofer are referenced in content.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Regional players

• Eurofarma Colombia: Brazilian-headquartered LATAM pharmaceutical group with expanding operations across the Andean region, including Colombia — comparable generic and branded prescription footprint operating in similar regional regulatory and commercial environments.
• Laboratorios Chile (Grupo Bagó/Laboratorios Chile ecosystem): Chilean pharmaceutical manufacturer with regional presence across South America offering generic and branded products in comparable therapeutic categories — similar LATAM regulatory context and pharmacy-driven distribution model, though geographically anchored outside Colombia.

Direct peers

• Genfar: Colombian generic pharmaceutical manufacturer with broad therapeutic coverage and pharmacy distribution — a direct domestic competitor in the same prescription and OTC categories where Farma de Colombia operates.
• Procaps: Latin American pharmaceutical company with Colombian operations offering generics, branded products, and soft-gel/sterile manufacturing capabilities — competes in similar therapeutic categories and serves similar physician and pharmacy channels.
• La Santé: Colombian pharmaceutical laboratory with a national generic and branded portfolio sold through pharmacies and to healthcare professionals — overlapping with Farma de Colombia in antibiotics, GI, and consumer health categories.
• Laboratorios Bussié (Bussié): Colombian pharmaceutical laboratory producing branded generics and specialty products across multiple therapeutic areas — directly comparable scale, product mix, and pharmacy-led distribution model.
• Tecnoquímicas (MK): One of Colombia's largest and most diversified national pharmaceutical laboratories, offering branded and generic prescription and OTC products across multiple therapeutic categories — directly comparable to Farma de Colombia's portfolio breadth and sales model.

Broad incumbents

• Bagó Colombia: Colombian arm of the Argentine-founded Bagó Laboratories group, a broad LATAM incumbent offering branded pharmaceuticals across many therapeutic categories — comparable product breadth but with larger group backing and broader regional presence.
• Bayer Colombia: Multinational pharmaceutical and consumer health company with established Colombian operations in cardiovascular, women's health, and OTC — overlaps with Farma de Colombia's prescription and OTC categories while operating at a global scale.
• Sanofi Colombia: Local subsidiary of global pharmaceutical major Sanofi, offering branded prescription and consumer health products across cardiovascular, vaccines, and other categories — competes with Farma de Colombia in overlapping therapeutic areas as part of a much wider multinational portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCoCX2YT4bxEGY2Kjnj8GnZw
• Facebookfacebook.com/FarmadeColombia60
• LinkedInlinkedin.com/company/farma-de-colombia
• Instagraminstagram.com/farmadecolombia_60

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Farma de Colombia